Always great chatting with our friends at the Cystic Fibrosis Foundation - North Central Florida Chapter about their latest initiatives and NEW life-changing drugs that are being produced from the funds CFF is able to raise!
Recently the FDA approved Trikafta™ for people with cystic fibrosis age 12 and older who have at least one copy of the F508del mutation. This drug is estimated to help 90% of the Cystic Fibrosis patient population.
Thanks to the North Central Florida Chapter Development Director, Meredith Chambers, for educating our staff about the medical findings! #501(c)3sUnite
